Vitestro’s Aletta wins FDA De Novo authorization as robotic phlebotomy moves toward US clinics
FDA authorizes Vitestro’s Aletta robotic blood draw device via De Novo. See how its clinical data could reshape outpatient phlebotomy.
Medical Devices & Diagnostics